What is Venus?
Venus specializes in clinically validated and user-friendly medical aesthetic equipment designed for clinics across the United States and Canada. Their product portfolio features advanced systems for body contouring, multi-treatment applications, radio frequency therapies, and laser hair removal. The company emphasizes safe, effective treatments with proven results, supported by extensive industry experience and a commitment to client success through comprehensive onboarding, business growth initiatives, and technical assistance. Clinics value Venus for its innovative technology, dependable performance, and robust after-sales support, which enhance both operational efficiency and patient satisfaction. Key offerings include specialized body contouring machines, facial aesthetic equipment, and advanced diode laser hair removal systems.
How much funding has Venus raised?
Venus has raised a total of $143.8M across 9 funding rounds:
Private Equity
$10M
Debt
$20M
Private Equity
$38M
Multiple Rounds
$55.3M
Share Placement
$17M
Debt
$2M
Private Equity
$1.5M
Private Equity (2014): $10M with participation from Longitude Capital
Debt (2015): $20M led by Oxford Finance
Private Equity (2017): $38M supported by HealthQuest Capital and Essex Woodlands
Share Placement (2020): $22.3M featuring SEDCO Capital, HealthQuest Capital, and Essex Woodlands
Debt (2020): $2M backed by PPP
Share Placement (2020): $31M with participation from Lincoln Park Capital Fund , LLC
Share Placement (2021): $17M led by Masters Special Situations, HealthQuest Capital, and Essex Woodlands
Debt (2025): $2M supported by Madryn Asset Management
Private Equity (2026): $1.5M, investors not publicly disclosed
Key Investors in Venus
Essex Woodlands
With over $4 billion raised since inception, EW Healthcare Partners is one of the largest and oldest private healthcare investment firms and seeks to make growth equity investments in fast growing commercial-stage healthcare companies in the pharmaceutical, medical device, diagnostics, and technology-enabled services sectors in the United States and in Europe. Since its founding in 1985, EW Healthcare Partners has maintained its singular commitment to the healthcare industry and has been a long-term investor in over 150 healthcare companies, ranging across sectors, stages and geographies.
HealthQuest Capital
HealthQuest Capital is a venture capital firm focused on investing in innovative healthcare companies, particularly in the medical device, diagnostics, and healthcare IT sectors. They aim to support companies that have the potential to significantly improve patient outcomes and reduce healthcare costs.
Oxford Finance
Oxford Finance, founded in 2002, is a specialty finance firm offering flexible financial solutions to healthcare and life sciences companies worldwide, focusing on debt financing and venture debt.
What's next for Venus?
With a significant influx of capital, Venus is poised for accelerated expansion and further innovation in the medical aesthetics industry. The recent major strategic investment suggests a focus on scaling operations, enhancing research and development for next-generation equipment, and potentially broadening its market reach. The company's history of securing diverse funding types, including private equity, debt, and share placements, indicates a robust financial strategy aimed at sustainable growth. Future endeavors will likely involve strengthening its competitive edge through technological advancements and expanding its service offerings to meet the evolving demands of clinics and patient preferences in aesthetic treatments.
See full Venus company page
